Nu Skin Enterprises announces partial exercise of over-allotment option

Nu Skin Enterprises, Inc. (NYSE: NUS) announced today the closing of a partial over-allotment option exercise by the underwriters of 569,000 shares of its Class A common stock at $27.00 per share, pursuant to an option granted to the underwriters in connection with its previously announced underwritten secondary public offering of 4.46 million shares of its Class A common stock at $27.00 per share. The shares were sold by three of the Company's founders who currently serve as members of the Company's Board of Directors. No shares were sold by the company, nor did the company receive any proceeds.

J.P. Morgan Securities Inc. and Deutsche Bank Securities Inc. acted as joint book-running managers for the offering. Canaccord Genuity Inc., Stifel, Nicolaus & Company, Incorporated, Avondale Partners, LLC, Sidoti & Company, LLC, and Moelis & Company LLC were co-managers of the offering. The offering of these securities was made by the selling shareholders only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from J.P. Morgan Securities Inc., Attn: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Telephone: 1-866-803-9204; or Deutsche Bank Securities Inc., Attention: Prospectus Department, 100 Plaza One, Jersey City, NJ 07311; Telephone 1-800-503-4611, or by emailing [email protected].

A shelf registration statement relating to the offering of these securities has previously been filed with the U.S. Securities and Exchange Commission and has become effective.

SOURCE Nu Skin Enterprises, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can exercise undo sitting's health risks? New study suggests vigorous activity helps